pubmed-article:16283486 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C0036536 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C0036537 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C0699040 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C1332712 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C1444748 | lld:lifeskim |
pubmed-article:16283486 | lifeskim:mentions | umls-concept:C1723831 | lld:lifeskim |
pubmed-article:16283486 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16283486 | pubmed:dateCreated | 2005-11-11 | lld:pubmed |
pubmed-article:16283486 | pubmed:abstractText | PCK3145 is a synthetic peptide corresponding to amino acids 31-45 of prostate secretory protein 94, which can reduce experimental skeletal metastases and prostate tumor growth in vivo. Part of its biological action involves the reduction of circulating plasma matrix metalloproteinase (MMP)-9, a crucial mediator in extracellular matrix (ECM) degradation during tumor metastasis and cancer cell invasion. The antimetastatic mechanism of action of PCK3145 is however, not understood. | lld:pubmed |
pubmed-article:16283486 | pubmed:language | eng | lld:pubmed |
pubmed-article:16283486 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16283486 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16283486 | pubmed:issn | 0262-0898 | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:BéliveauRicha... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:AnnabiBorhane... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:WuJinzi JJJ | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:RabbaniShafaa... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:HawkinsRobert... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:GardeSeemaS | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:WisniewskiJan... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:PanchalChandr... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:RuizMarciaM | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:BouzeghraneMo... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:DaigneaultLuc... | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:DuludeHélèneH | lld:pubmed |
pubmed-article:16283486 | pubmed:author | pubmed-author:CurrieJean-Ch... | lld:pubmed |
pubmed-article:16283486 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16283486 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:16283486 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16283486 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16283486 | pubmed:pagination | 429-39 | lld:pubmed |
pubmed-article:16283486 | pubmed:dateRevised | 2008-8-14 | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:meshHeading | pubmed-meshheading:16283486... | lld:pubmed |
pubmed-article:16283486 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16283486 | pubmed:articleTitle | A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis. | lld:pubmed |
pubmed-article:16283486 | pubmed:affiliation | Laboratoire d'Oncologie Moléculaire, Département de Chimie-Biochimie, Université du Québec à Montréal, Montreal, Quebec, Canada. | lld:pubmed |
pubmed-article:16283486 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16283486 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16283486 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16283486 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16283486 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16283486 | lld:pubmed |